The Sympathetic Nervous System in Heart Failure

Triposkiadis, Filippos, Karayannis, George, Giamouzis, Grigorios, Skoularigis, John, Louridas, George, Butler, Javed·2009·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2009.05.015

Cited by (979)

Items 101–200 of 979

  1. ‘Ryanopathy’: causes and manifestations of RyR2 dysfunction in heart failure
    Andriy E. Belevych, Przemysław Radwański, Cynthia A. Carnes, Sándor Györke · 2013 · Cardiovascular Research
  2. Non-pharmacological modulation of the autonomic tone to treat heart failure
    Jagmeet P. Singh, Jagdesh Kandala, A. John Camm · 2013 · European Heart Journal
  3. Cardiorenal Syndrome and Heart Failure—Challenges and Opportunities
    Haran Yogasundaram, Mark C. Chappell, Branko G. Braam, Gavin Y. Oudit · 2019 · Canadian Journal of Cardiology
  4. Vasopressor and Inotrope Therapy in Cardiac Critical Care
    Jacob Colin Jentzer, Steven M. Hollenberg · 2020 · Journal of Intensive Care Medicine
  5. Pediatric and adult dilated cardiomyopathy represent distinct pathological entities
    Meghna D. Patel, Mohan Jayaram, Caralin Schneider, Geetika Bajpai, Enkhsaikhan Purevjav, Charles E. Canter, Jeffrey Allen Towbin, Andrea L. Bredemeyer, Kory J. Lavine · 2017 · JCI Insight
  6. Sympathetic activation in heart failure
    Edoardo Gronda, Veronica Dusi, Emilia D’Elia, Massimo Iacoviello, E Benvenuto, Emilio Vanoli · 2022 · European Heart Journal Supplements
  7. Heart Failure Severity, as Determined by Loop Diuretic Dosages, Predicts the Risk of Developing Diabetes After Myocardial Infarction: A Nationwide Cohort Study
    Charlotte Andersson, Mette Lykke Norgaard, Peter Riis Hansen, Emil Loldrup Fosbøl, Michelle Schmiegelow, Peter Ejvin Weeke, Jonas Bjerring Olesen, Jakob Raunsø, Casper H. Jørgensen, Allan Arthur Vaag et al. · 2010 · European Journal of Heart Failure
  8. Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes?
    Maria Mizamtsidi, Stavroula Α. Paschou, Julia Grapsa, Andromachi Vryonidou · 2016 · European Journal of Clinical Investigation
  9. Modulation of β-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5
    Ho, David, Yan, Lin, Iwatsubo, Kousaku, Vatner, Dorothy E., Vatner, Stephen F. · 2010 · Heart Failure Reviews
  10. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension
    Luca Donazzan, Felix Mahfoud, Sebastian Ewen, Christian Ukena, Bodo Cremers, Carl‐Martin Kirsch, Dirk Hellwig, Tareq Eweiwi, Samer Ezziddin, Murray Esler et al. · 2015 · Clinical Research in Cardiology
  11. Cardiac autonomic imaging with SPECT tracers
    Mark I. Travin · 2012 · Journal of Nuclear Cardiology
  12. The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
    Daniele Masarone, Maria Luigia Martucci, Vittoria Errigo, Giuseppe Pacileo · 2021 · Journal of Cardiovascular Development and Disease
  13. Impact of Obstructive Sleep Apnea and Sympathetic Nervous System on Cardiac Health: A Comprehensive Review
    Antonino Maniaci, Salvatore Lavalle, Federica Maria Parisi, Marco Barbanti, Salvatore Giuseppe Cocuzza, Giannicola Iannella, Giuseppe Magliulo, Annalisa Pace, Mario Lentini, Edoardo Masiello et al. · 2024 · Journal of Cardiovascular Development and Disease
  14. Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: A prospective, randomized, controlled, pilot study
    Weijie Chen, Zhiyu Ling, Yanping Xu, Zengzhang Liu, Li Su, Huaan Du, Peilin Xiao, Xianbin Lan, Qijun Shan, Yuehui Yin · 2016 · Catheterization and Cardiovascular Interventions
  15. Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC)
    Karl-Heinz Ladwig, Thomas C. Baghai, Frank Doyle, Mark Hamer, Christoph Herrmann‐Lingen, Evelyn Kunschitz, Cédric Lemogne, Margarita Beresnevaitė, Angelo Compare, Roland von Känel et al. · 2022 · European Journal of Preventive Cardiology
  16. Blockade of β‐adrenoceptors restores the GRK2‐mediated adrenal α2‐adrenoceptor–catecholamine production axis in heart failure
    Giuseppe Rengo, Anastasios Lymperopoulos, Carmela Zincarelli, Grazia Daniela Femminella, Daniela Liccardo, Gennaro Pagano, Claudio de Lucia, Alessandro Cannavò, Paola Gargiulo, Nicola Ferrara et al. · 2012 · British Journal of Pharmacology
  17. Novel Interventional Therapies to Modulate the Autonomic Tone in Heart Failure
    Neal A. Chatterjee, Jagmeet P. Singh · 2015 · JACC Heart Failure
  18. Effects of whole-body vibration on driver drowsiness: A review
    Mohammed H.U. Bhuiyan, Mohamad Fard, Stephen R. Robinson · 2022 · Journal of Safety Research
  19. Heart Failure and Loss of Metabolic Control
    Zhao V. Wang, Dan ‘Leslie’ Li, Joseph A. Hill · 2013 · Journal of Cardiovascular Pharmacology
  20. Effect of long-term remote ischemic conditioning in patients with chronic ischemic heart failure
    Kasper Pryds, Roni Ranghoej Nielsen, Anders Jorsal, Mona Sahlholdt Hansen, Steffen Ringgaard, Jens Christian Refsgaard, Won Yong Kim, Annemette Krintel Petersen, Hans Erik Bøtker, Michael Rahbek Schmidt · 2017 · Basic Research in Cardiology
  21. Nuclear Imaging of the Cardiac Sympathetic Nervous System
    Jason G.E. Zelt, Robert A. deKemp, Benjamin H. Rotstein, Girish M. Nair, Jagat Narula, Ali Reza Ahmadi, Rob S. Beanlands, Lisa Marie Mielniczuk · 2019 · JACC. Cardiovascular imaging
  22. Cognitive function and left ventricular assist device implantation
    Geetha Bhat, Gardner L. Yost, Edward Mahoney · 2015 · The Journal of Heart and Lung Transplantation
  23. Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis
    Raquel Yotti, Cristina Ripoll, Yolanda Benito, María‐Vega Catalina, Jaime Elı́zaga, Diego Rincón, Francisco Fernández‐Avilés, Javier Bermejo, Rafael Bañares · 2017 · Hepatology
  24. Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro
    Fotios G. Pitoulis, Raquel Núñez-Toldrà, Ke Xiao, Worrapong Kit‐Anan, Saskia Mitzka, Richard J. Jabbour, Siân E. Harding, Filippo Perbellini, Thomas Thum, Pieter P. de Tombe et al. · 2021 · Cardiovascular Research
  25. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome
    Susanne Unverzagt, Lisa Wachsmuth, Katharina Hirsch, Hölger Thiele, Michael Buerke, Johannes Haerting, Karl Werdan, Roland Prondzinsky · 2014 · Cochrane Database of Systematic Reviews
  26. Diabetic cardiovascular autonomic neuropathy: clinical implications
    Georgios Karayannis, Grigorios Giamouzis, Dennis V. Cokkinos, John S. Skoularigis, Filippos K. Triposkiadis · 2012 · Expert Review of Cardiovascular Therapy
  27. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction
    Ambarish Pandey, Harsh B. Golwala, Shubin Sheng, Adam D. DeVore, Adrian F. Hernandez, Deepak L. Bhatt, Paul A. Heidenreich, Clyde W. Yancy, James A. de Lemos, Gregg C. Fonarow · 2016 · JAMA Cardiology
  28. Prediction of Heart Failure Decompensation Events by Trend Analysis of Telemonitoring Data
    Jorge M. O. Henriques, P. Carvalho, Simão Paredes, Teresa Rocha, J. Habetha, M. Antunes, João Morais · 2014 · IEEE Journal of Biomedical and Health Informatics
  29. LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse
    J Lu, Xianwei Wang, W Wang, Harish Muniyappa, Chang Ping Hu, Sona Mitra, B Long, Kumuda C. Das, Jawahar Lal Mehta · 2011 · Gene Therapy
  30. Cardiovascular Disorders Associated with Obstructive Sleep Apnea
    2011 · Advances in cardiology
  31. Establishing Prognosis in Heart Failure: A Multimarker Approach
    Eric S. Ketchum, Wayne C. Levy · 2011 · Progress in Cardiovascular Diseases
  32. Loss of PI3Kγ Enhances cAMP-Dependent MMP Remodeling of the Myocardial N-Cadherin Adhesion Complexes and Extracellular Matrix in Response to Early Biomechanical Stress
    Danny Guo, Zamaneh Kassiri, Ratnadeep Basu, Fung Lan Chow, Vijay Kandalam, Federico Damilano, Wenbin Liang, Seigo Izumo, Emilio Hirsch, Josef Martin Penninger et al. · 2010 · Circulation Research
  33. Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
    Rishi K. Trivedi, David J. Polhemus, Zhen Li, Daniel Yoo, Hiroshi Koiwaya, Amy L. Scarborough, Traci T. Goodchild, David J. Lefer · 2018 · Journal of the American Heart Association
  34. Right heart in pulmonary hypertension: from adaptation to failure
    Xianfeng Ren, Roger A. Johns, Wei Dong Gao · 2019 · Pulmonary Circulation
  35. The association between PTSD and cardiovascular disease and its risk factors in male veterans of the Iraq/Afghanistan conflicts: a systematic review
    Daniel Mark Dyball, Sarah Evans, Christopher John Boos, Sharon A. M. Stevelink, Nicola T. Fear · 2019 · International Review of Psychiatry
  36. Telemonitoring in Chronic Heart Failure: A Systematic Review
    Giamouzis, Gregory, Mastrogiannis, Dimos, Koutrakis, Konstantinos, Karayannis, George, Parisis, Charalambos, Rountas, Chris, Adreanides, Elias, Dafoulas, George E., Stafylas, Panagiotis C., Skoularigis, John et al. · 2012 · Cardiology Research and Practice
  37. Psychological stress in heart failure: a potentially actionable disease modifier
    Kristie M. Harris, Daniel Louis Jacoby, Rachel J. Lampert, Richard J. Soucier, Matthew M. Burg · 2020 · Heart Failure Reviews
  38. Subtype-dependent regulation of Gβγ signalling
    Mithila Tennakoon, Kanishka Senarath, Dinesh Kankanamge, Kasun Ratnayake, Dhanushan Wijayaratna, Koshala Olupothage, Sithurandi Ubeysinghe, Kimberly Martins-Cannavino, Terence E. Hébert, Ajith Karunarathne · 2021 · Cellular Signalling
  39. Relation of Short-Term Heart Rate Variability to Incident Heart Failure (from the Multi-Ethnic Study of Atherosclerosis)
    Sidharth A. Shah, Thomas R. Kambur, Cheeling Chan, David M. Herrington, Kiang Liu, Sanjiv Jayendra Shah · 2013 · The American Journal of Cardiology
  40. Cardiopulmonary exercise testing and prognosis in heart failure due to systolic left ventricular dysfunction: a validation study of the European Society of Cardiology Guidelines and Recommendations (2008) and further developments
    Ugo Corrà, Andrea Giordano, Alessandro Mezzani, Marco Gnemmi, Massimo Pistono, Roberto Caruso, Pantaleo Giannuzzi · 2011 · European Journal of Preventive Cardiology
  41. Managing Therapeutic Competition in Patients with Heart Failure, Lower Urinary Tract Symptoms and Incontinence
    Cara Tannenbaum, Kristina Johnell · 2013 · Drugs & Aging
  42. Myocardial β2‐adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure
    Giuseppe Rengo, Carmela Zincarelli, Grazia Daniela Femminella, Daniela Liccardo, Gennaro Pagano, Claudio de Lucia, Giovanna Giuseppina Altobelli, Vincenzo Cimini, Donatella Ruggiero, P Perrone‐Filardi et al. · 2012 · British Journal of Pharmacology
  43. Incremental Prognostic Value of Echocardiographic Strain and Its Association With Mortality in Cancer Patients
    Isaac B. Rhea, Sarada Uppuluri, Stephen G. Sawada, Bryan Paul Schneider, Harvey Feigenbaum · 2015 · Journal of the American Society of Echocardiography
  44. S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence
    Hiroki Hayashi, Douglas T. Hess, Rongli Zhang, Keiki Sugi, Huiyun Gao, Bea L. Tan, Dawn E. Bowles, Carmelo A. Milano, Mukesh K. Jain, Walter J. Koch et al. · 2018 · Molecular Cell
  45. Maternal Allopurinol Prevents Cardiac Dysfunction in Adult Male Offspring Programmed by Chronic Hypoxia During Pregnancy
    Youguo Niu, Andrew D. Kane, Ciara Lusby, Beth J. Allison, Yi Yi Chua, Joepe J. Kaandorp, Rhiannon Nevin-Dolan, Thomas J. Ashmore, Heather L. Blackmore, Jan B Derks et al. · 2018 · Hypertension
  46. Regulation of β-Adrenergic Receptors in the Heart: A Review on Emerging Therapeutic Strategies for Heart Failure
    Warisara Parichatikanond, Ratchanee Duangrat, Hitoshi Kurose, Supachoke Mangmool · 2024 · Cells
  47. Association of Heart Rate with Mortality in Sinus Rhythm and Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction
    Ulrik Sartipy, Gianluigi Savarese, Ulf Dahlström, Michael L.X. Fu, Lars H. Lund · 2019 · European Journal of Heart Failure
  48. Curcumin attenuates cadmium-induced atherosclerosis by regulating trimethylamine-N-oxide synthesis and macrophage polarization through remodeling the gut microbiota
    Jiexin Zhang, Caiwen Ou, Minsheng Chen · 2022 · Ecotoxicology and Environmental Safety
  49. Inhibition of hydrogen sulfide restores normal breathing stability and improves autonomic control during experimental heart failure
    Rodrigo Del Río, Noah Justin Marcus, Harold D. Schultz · 2013 · Journal of Applied Physiology
  50. Loss of autophagy protein ATG5 impairs cardiac capacity in mice and humans through diminishing mitochondrial abundance and disrupting Ca2+ cycling
    Senka Ljubojević-Holzer, Simon C Kraler, Nataša Djalinac, Mahmoud Abdellatif, Julia Voglhuber, Julia Schipke, Marlene Schmidt, Katharina-Maria Kling, Greta Therese Franke, Viktoria Herbst et al. · 2021 · Cardiovascular Research
  51. Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart Failure
    Yu‐Long Li · 2022 · International Journal of Molecular Sciences
  52. Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer’s disease
    Andrea Elia, Silvia Fossati · 2023 · Frontiers in Physiology
  53. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones:biomarkers or mediators
    Alessia Buglioni, John C. Jr Burnett · 2014 · Clinica Chimica Acta
  54. Sympathetic neural overdrive in congestive heart failure and its correlates
    Guido M. Grassi, Graziella D’Arrigo, Anna Pisano, Davide Bolignano, Francesca Mallamaci, Raffaella Dell’Oro, Fosca Quarti‐Trevano, Gino Seravalle, Giuseppe Mancia, Carmine Zoccali · 2019 · Journal of Hypertension
  55. Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors
    Maxime Caru, Denis Corbin, Delphine Périé, Valérie Lemay, Jacques Delfrate, Simon Drouin, Laurence Bertout, Maja Krajinović, Caroline Laverdière, Grégor Andelfinger et al. · 2019 · Clinical Research in Cardiology
  56. Molecular Mechanisms Underlying Heart Failure and Their Therapeutic Potential
    Oveena Fonseka, Sanskruti Ravindra Gare, Xinyi Chen, Jiayan Zhang, Nasser hawimel o Alatawi, Claire Ross, Wei Liu · 2025 · Cells
  57. Anemia in Heart Failure Patients
    Michael G. Alexandrakis, George Tsirakis · 2012 · ISRN Hematology
  58. Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?
    Gerard O. Oghlakian, İlke Sipahi, James Chen-Tson Fang · 2011 · Mayo Clinic Proceedings
  59. A general theory of acute and chronic heart failure
    David Hunter MacIver, Mark Dayer, Andrew J.I. Harrison · 2012 · International Journal of Cardiology
  60. Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure
    Johanna Elisabeth Emmens, Jozine M. ter Maaten, Kevin Damman, Dirk Jan van Veldhuisen, Rudolf A. de Boer, Joachim Struck, Andreas Bergmann, Iziah Edwin Sama, Koen W. Streng, Stefan D. Anker et al. · 2019 · Circulation Heart Failure
  61. Pharmacological assessment of zebrafish-based cardiotoxicity models
    Monika Maciąg, Artur Wnorowski, Małgorzata Mierzejewska, Anita Płazińska · 2022 · Biomedicine & Pharmacotherapy
  62. Dynamic remodeling of the guinea pig intrinsic cardiac plexus induced by chronic myocardial infarction
    Jean C. Hardwick, Shannon E. Ryan, Éric Beaumont, Jeffrey L. Ardell, E. Marie Southerland · 2013 · Autonomic Neuroscience
  63. Targeting the autonomic nervous system: Measuring autonomic function and novel devices for heart failure management
    Hitesh C Patel, Stuart David Rosen, Alistair C Lindsay, Carl Hayward, Alexander Richard Lyon, Carlo Di Mario · 2013 · International Journal of Cardiology
  64. Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure ethiology and correlates to clinical variables
    Fermí Montó, Eduardo Oliver, Diana Vicente, Joaquı́n Rueda, Jaume Agüero, Luís Almenar, Maria Dolores Ivorra, Domingo Barettino, Pilar D’Ocón · 2012 · American Journal of Physiology-Heart and Circulatory Physiology
  65. Electroacupuncture improves cardiac function and remodeling by inhibition of sympathoexcitation in chronic heart failure rats
    Luyao Ma, Baiping Cui, Yongfeng Shao, Buqing Ni, Weiran Zhang, Yonggang Luo, Shijiang Zhang · 2014 · American Journal of Physiology-Heart and Circulatory Physiology
  66. Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failure
    Sanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi‐Makaya, Shouji Matsushima, Mamoru Sakakibara, Naoki Ishimori, Daisuke Goto, Hiroyuki Tsutsui · 2013 · Journal of Cardiology
  67. Angiotensin II type 1 receptor expression in astrocytes is upregulated leading to increased mortality in mice with myocardial infarction-induced heart failure
    Kengo Isegawa, Yoshitaka Hirooka, Masato Katsuki, Takuya Kishi, Kenji Sunagawa · 2014 · American Journal of Physiology-Heart and Circulatory Physiology
  68. Risk Stratification of Sudden Cardiac Death in Patients with Heart Failure: An update
    Daniele Masarone, Giuseppe Limongelli, Ernesto Ammendola, Marina Verrengia, Rita Gravino, Giuseppe Pacileo · 2018 · Journal of Clinical Medicine
  69. The wonders of the Wanderer
    Jennifer A. Clancy, Susan A. Deuchars, Jim Deuchars · 2012 · Experimental Physiology
  70. Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice
    Giovanni Fajardo, Mingming Zhao, Takashi Urashima, Sara Farahani, Dong‐Qing Hu, Sushma Reddy, Daniel Bernstein · 2013 · Journal of Molecular and Cellular Cardiology
  71. Common Genetic Variation, Residential Proximity to Traffic Exposure, and Left Ventricular Mass: The Multi-Ethnic Study of Atherosclerosis
    Victor C. Van Hee, Sara Dubowsky Adar, Adam A. Szpiro, R. Graham Barr, Ana Victoria Diez Roux, David A. Bluemke, Lianne A. Sheppard, Edward Allen Gill, Hossein Bahrami, Christina L. Wassel et al. · 2010 · Environmental Health Perspectives
  72. Regulation of G Protein βγ Signaling
    Kanishka Senarath, Dinesh Kankanamge, Saroopa P. Samaradivakara, Kasun Ratnayake, Mithila Tennakoon, Ajith Karunarathne · 2018 · International review of cytology
  73. Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling
    Sirirat Surinkaew, Mona Aflaki, Abhijit R Takawale, Yu Chen, Xiaoyan Qi, Marc‐Antoine Gillis, Yanfen Shi, Jean‐Claude Tardif, Nipon Chattipakorn, Stanley Nattel · 2018 · Cardiovascular Research
  74. Examining the Role of Psychosocial Stressors in Hypertension
    Komal Marwaha · 2022 · Journal of Preventive Medicine and Public Health
  75. Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes
    Mazen Saadi Albaghdadi, Mihai Gheorghiade, Bertram Pitt · 2011 · European Heart Journal
  76. The pathophysiological role of natriuretic peptide-RAAS cross talk in heart failure
    Francesco Rossi, Annamaria Mascolo, Vincenzo Mollace · 2016 · International Journal of Cardiology
  77. A systematic review of the effects of transcutaneous auricular vagus nerve stimulation on baroreflex sensitivity and heart rate variability in healthy subjects
    Danesh Soltani, Bayan Azizi, Sepehr Sima, Kiarash Tavakoli, Negin Sadat Hosseini Mohammadi, Abdol‐Hossein Vahabie, Kaveh Akbarzadeh-Sherbaf, Ali Vasheghani‐Farahani · 2023 · Clinical Autonomic Research
  78. The sympathetic nervous system in heart failure revisited
    Filippos K. Triposkiadis, Αlexandros Briasoulis, Takeshi Kitai, Dimitrios E. Magouliotis, Thanos Athanasiou, John S. Skoularigis, Andrew V. Xanthopoulos · 2023 · Heart Failure Reviews
  79. Physiology and pharmacology of the cardiovascular adrenergic system
    Anastasios Lymperopoulos · 2013 · Frontiers in Physiology · Retracted
  80. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial
    Jun R. Chiong, Sonnie Kim, Jay Lin, Rudell Christian, Joseph F. Dasta · 2011 · Journal of Medical Economics
  81. Adrenergic Downregulation in Critical Care: Molecular Mechanisms and Therapeutic Evidence
    Alessandro Belletti, Giovanni Landoni, В. В. Ломиворотов, Alessandro Oriani, Silvia Ajello · 2019 · Journal of Cardiothoracic and Vascular Anesthesia
  82. Role of inflammation, oxidative stress, and autonomic nervous system activation during the development of right and left cardiac remodeling in experimental pulmonary arterial hypertension
    Alexsandra Zimmer, Rayane Brinck Teixeira, Jéssica Hellen Poletto Bonetto, Alan Christhian Bahr, Patrick Türck, Alexandre Luz de Castro, Cristina Campos Carraro, Fernanda Visioli, Tânia Regina Gattelli Fernandes, Karina Rabello Casali et al. · 2019 · Molecular and Cellular Biochemistry
  83. Myocardial Contractility: Historical and Contemporary Considerations
    William W. Muir, Robert L. Hamlin · 2020 · Frontiers in Physiology
  84. Resting Heart Rate and Incident Heart Failure in Apparently Healthy Men and Women in the EPIC-Norfolk Study
    Pfister, Roman, Michels, Guido, Sharp, Stephen J., Luben, Robert, Wareham, Nick J., Khaw, Kay-Tee · 2012 · European Journal of Heart Failure
  85. Brain mechanisms of sympathetic activation in heart failure: Roles of the renin-angiotensin system, nitric oxide and pro-inflammatory cytokines (Review)
    BIN XU, Hongli Li · 2015 · Molecular Medicine Reports
  86. Prognostic Value of Lymphocyte G Protein-Coupled Receptor Kinase-2 Protein Levels in Patients With Heart Failure
    Giuseppe Rengo, Gennaro Pagano, Pasquale Perrone Filardi, Grazia Daniela Femminella, Valentina Parisi, Alessandro Cannavò, Daniela Liccardo, Klara Komici, Giuseppina Gambino, Maria Loreta D’Amico et al. · 2016 · Circulation Research
  87. Angiotensin II receptor blockers improve endothelial dysfunction associated with sympathetic hyperactivity in metabolic syndrome
    Takuya Kishi, Yoshitaka Hirooka, Satomi Konno, Kenji Sunagawa · 2012 · Journal of Hypertension
  88. Adrenergic Regulation of Drp1-Driven Mitochondrial Fission in Cardiac Physio-Pathology
    Bong Sook Jhun, Jin O‐Uchi, Stephanie M. Adaniya, Michael W. Cypress, Yisang Yoon · 2018 · Antioxidants
  89. Renin Activity in Heart Failure with Reduced Systolic Function—New Insights
    Ryan D. Sullivan, Radhika M. Mehta, Ranjana Tripathi, Guy L. Reed, Inna P. Gladysheva · 2019 · International Journal of Molecular Sciences
  90. Nuclear Localization of α1A‐Adrenergic Receptors Is Required for Signaling in Cardiac Myocytes: An “Inside‐Out” α1‐AR Signaling Pathway
    Steven C. Wu, Erika F. Dahl, Casey D. Wright, Andrew L Cypher, Chastity L. Healy, Timothy D. O’Connell · 2014 · Journal of the American Heart Association
  91. Chloride in Heart Failure Syndrome: Its Pathophysiologic Role and Therapeutic Implication
    Hajime Kataoka · 2021 · Cardiology and Therapy
  92. The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes
    Pupalan Iyngkaran, Namrata Sadanand Anavekar, William Majoni, Merlin C. Thomas · 2013 · Diabetes & Metabolism
  93. Biomarkers and physiopathology in the cardiorenal syndrome
    Antoine Bouquegneau, Jean-Marie Krzesinski, Pierre Delanaye, Etienne Cavalier · 2014 · Clinica Chimica Acta
  94. Dipeptidyl peptidase‐4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
    Tharnwimol Inthachai, Suree Lekawanvijit, Sirinart Kumfu, Nattayaporn Apaijai, Wanpitak Pongkan, Siriporn Chaisin Chattipakorn, Nipon Chattipakorn · 2015 · Experimental Physiology
  95. Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart
    Dmitry A. Terentyev, Shanna Hamilton · 2016 · Journal of Molecular and Cellular Cardiology
  96. Cardiac Fibroblasts Mediate a Sexually Dimorphic Fibrotic Response to β‐Adrenergic Stimulation
    Angela K. Peter, Cierra J. Walker, Tova L. Ceccato, Christa L. Trexler, Christopher D. Ozeroff, Kimberly R Lugo, Amy Perry, Kristi S. Anseth, Leslie Anne Leinwand · 2021 · Journal of the American Heart Association
  97. Prediabetes and insulin resistance in a population of patients with heart failure and reduced or preserved ejection fraction but without diabetes, overweight or hypertension
    Son Kim Tran, Ngo Hoang Toan, Nguyen Thang, Huynh Le Trong Tuong, Hoang Anh Tien, Nguyen Hai Thuy, Huynh Van Minh, Paul Elie Valensi · 2022 · Cardiovascular Diabetology
  98. Integrated mass spectrometry imaging reveals spatial-metabolic alteration in diabetic cardiomyopathy and the intervention effects of ferulic acid
    Yanhua Liu, Xin Zhang, Shu Yang, Zhi Zhou, Tian Lu, Wanfang Li, Jinfeng Wei, Zeper Abliz, Zhonghua Wang · 2023 · Journal of Pharmaceutical Analysis
  99. Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
    Marios Zisis, Maria Eleni Chondrogianni, Θεόδωρος Ανδρουτσάκος, Ilias Rantos, Evangelos K. Oikonomou, Antonios Chatzigeorgiou, Eva N. Kassi · 2025 · Biomolecules
  100. Heart failure-induced changes of voltage-gated Ca 2+ channels and cell excitability in rat cardiac postganglionic neurons
    Huiyin Tu, Jinxu Liu, Dongze Zhang, Hong Zheng, Kaushik P. Patel, Kurtis G. Cornish, Wei-Zhong Wang, Robert L. Muelleman, Yu‐Long Li · 2013 · American Journal of Physiology-Cell Physiology